Ernie Lee is a Consultant at Innopiphany, bringing a background in Market Access Strategy, Health Economics and Outcomes Research, and M&A strategy and due diligence. Ernie’s responsibilities include engaging in strategic market entry, product launch, HEOR engagements, and market access and reimbursement. Past work includes go-to market strategy, revenue modelling, and health economics modelling with a focus on U.S. and EU5 regions. He has experience across a broad range of therapeutic areas with a focus on rare diseases, oncology, and Alzheimer’s Disease. Ernie previously served as a Consultant at Certara in the US Access Strategy group supporting pharmaceutical companies in commercial strategy and investors in acquisition strategy and due diligence. Ernie began his career as an Analyst and Associate at Innopiphany. Outside of work, Ernie enjoys skiing and running at a moderate pace. Ernie holds a Bachelor of Science in Biochemistry from the University of California Los Angeles.